GGrantIndex
← Search

CORE--DNA SYNTHESIS AND SEQUENCING

$0P30FY2000CANIH

Univ Of Med/Dent Nj-R W Johnson Med Sch, Piscataway NJ

Investigators

Linked publications, trials & patents

Trial NCT05639972Trial NCT05483491Trial NCT05296421Trial NCT04929015Trial NCT04920344Trial NCT04871516Trial NCT04751747Trial NCT04445844Trial NCT04294264Trial NCT04285268Trial NCT04253483Trial NCT04211259Trial NCT04179227Trial NCT04163952Trial NCT04146038Trial NCT04081688Trial NCT03902379Trial NCT03725449Trial NCT03677739Trial NCT03456843Trial NCT03448224Trial NCT03441321Trial NCT03428802Trial NCT03272633Trial NCT03257163Trial NCT03233555Trial NCT03229278Trial NCT03228147Trial NCT03112668Trial NCT03108911Trial NCT03102060Trial NCT03061175Trial NCT03028948Trial NCT02949284Trial NCT02885649Trial NCT02748564Trial NCT02699996Trial NCT02688517Trial NCT02688192Trial NCT02621398Trial NCT02526511Trial NCT02526498Trial NCT02458716Trial NCT02421575Trial NCT02420652Trial NCT02324621Trial NCT02324608Trial NCT02315196Trial NCT02295540Trial NCT02294617Trial NCT02250781Trial NCT02203604Trial NCT02203578Trial NCT02177838Trial NCT02144701Trial NCT02144675Trial NCT02105116Trial NCT01828476Trial NCT01694589Trial NCT01652014Trial NCT01649947Trial NCT01480154Trial NCT01417286Trial NCT01407562Trial NCT01303341Trial NCT01251172Trial NCT01032590Trial NCT01018836Trial NCT01009931Trial NCT01006369Trial NCT00996359Trial NCT00991315Trial NCT00966667Trial NCT00962845Trial NCT00946283Trial NCT00943709Trial NCT00939380Trial NCT00934895Trial NCT00909909Trial NCT00905918Trial NCT00900120Trial NCT00899808Trial NCT00899639Trial NCT00895115Trial NCT00891969Trial NCT00878657Trial NCT00866840Trial NCT00853125Trial NCT00813423Trial NCT00786682Trial NCT00770419Trial NCT00770055Trial NCT00769652Trial NCT00765765Trial NCT00749437Trial NCT00740805Trial NCT00728845Trial NCT00726596Trial NCT00669734Trial NCT00667901

Abstract

The DNA Synthesis and Sequencing Shared Resource of the Cancer Institute of New Jersey (CINJ) represents an expansion of the original Robert Wood Johnson Medical School (RWJMS) facility. This facility was established in 1985 with funds from the New Jersey Commission on Science and Technology and RWJMS. The overall purpose of this shared resource is to provide a centralized high quality, cost-effective facility for DNA synthesis and sequencing for use by CINJ members, the application of DNA sequencing, polymerase chain reactions, site-directed mutagenesis, hybridization, and structural studies is greatly facilitated at significant cost discounts over what individual laboratories could obtain. Additionally, specialized modified fluorescent oligonucleotides are required for Loss of Heterozygosity and Microsatellite Instability (LOH and MIN) fragment analysis, a cutting edge method for analysis of molecular mechanisms of tumor formation. The technical support and discounts for these specialty oligonucleotides greatly speeds the application of this method. Automated fluorescent sequencing the other service of the shared resource, provides much more data )generally 400 to 850 nucleotides) from a single loading than can be achieved by manual sequencing methods most researchers previously performed in their laboratories. The cost of such a system is prohibitively highly; only a shared resource such as this can maintain and operate this system efficiently. Additionally, electronic transcription of data eliminates errors inherent in manual transcription. The DNA Synthesis and Sequencing Shared Resource provides high quality service for members of CINJ, thus freeing them to focus on the application of these technologies in their research. CINJ members comprise 83% of all users (71% with peer- reviewed, funded research projects). Use by CINJ members increased 48% during the last grant period.

View original record on NIH RePORTER →